非侵入性框架核酸眼药滴用于视网膜施用
Shitai Zhu1,2, Qinglong Yan3, Lihua Wang1,4,2
1Division of Physical Biology, CAS Key Laboratory of Interfacial Physics and Technology, Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China.
ACS applied bio materials
|October 20, 2023
概括
这项研究引入了用于非侵入性眼睛治疗的新型DNA纳米结构. 这些框架核酸 (FNA) 通过眼滴有效地将药物输送到视网膜,克服了目前的注射限制.
科学领域:
- 眼科医生 眼科 眼科
- 纳米技术纳米技术
- 生物医学工程 生物医学工程
背景情况:
- 静脉内注射是治疗视网膜疾病的常见方法,但有显著的缺点.
- 这些包括眼部创伤,感染风险,以及由于频繁的药物管理,患者不适应治疗.
- 开发有效的非侵入性眼科药物输送到视网膜是具有挑战性的,因为视角膜等生物障碍.
研究的目的:
- 开发和评估尺寸和形状解析的光DNA框架,用于非侵入性视网膜药物输送.
- 评估这些纳米载体的效率和生物相容性,以便在视网膜中使用.
主要方法:
- 使用框架核酸 (FNA) 由于其生物相容性和可控制的纳米结构特性.
- 具有特定尺寸的工程四面体DNA纳米结构 (TDNs) (20bp边长).
- 在眼科背景下研究了这些TDN的视网膜传递效率和生物相容性.
主要成果:
- 具有20bp边长的四面体DNA纳米结构 (TDNs) 在6小时内证明了有效的视网膜透.
- 开发的基于FNA的纳米载体表现出极好的生物相容性.
- 优化FNA的大小和形状对于有效的非侵入性视网膜药物递送至关重要.
结论:
- 框架核酸为非侵入性视网膜药物递送提供了一个有希望的平台.
- 优化的DNA纳米结构可以克服眼睛的障碍,有效地到达视网膜.
- 这种方法为视网膜疾病的局部治疗提供了新的策略,改善了患者的遵守和安全.
相关概念视频
01:25Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:23Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...